Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
18.60
-1.49 (-7.42%)
At close: Apr 28, 2026, 4:00 PM EDT
18.25
-0.35 (-1.88%)
After-hours: Apr 28, 2026, 4:20 PM EDT
Aktis Oncology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 6.5 | 1.49 | - | - |
| Revenue Growth (YoY) | 336.92% | - | - | - |
| Cost of Revenue | 67.45 | 40.95 | 25.92 | - |
| Gross Profit | -60.95 | -39.47 | -25.92 | - |
| Selling, General & Admin | 13.73 | 12.58 | 8.88 | 5.46 |
| Research & Development | - | - | - | 14.3 |
| Operating Expenses | 13.73 | 12.58 | 8.88 | 19.76 |
| Operating Income | -74.68 | -52.05 | -34.79 | -19.76 |
| Interest & Investment Income | 11.01 | 8.1 | 5.38 | 1.65 |
| Other Non Operating Income (Expenses) | -0.06 | -0.03 | 0.78 | 0.19 |
| Pretax Income | -63.73 | -43.98 | -28.64 | -17.93 |
| Net Income | -63.73 | -43.98 | -28.64 | -17.93 |
| Net Income to Common | -63.73 | -43.98 | -28.64 | -17.93 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 |
| Shares Change (YoY) | 15.53% | 14.46% | 18.90% | - |
| EPS (Basic) | -78.34 | -62.46 | -46.55 | -34.65 |
| EPS (Diluted) | -78.34 | -62.46 | -46.55 | -34.65 |
| Free Cash Flow | -73.71 | 11.9 | -33.77 | -20.43 |
| Free Cash Flow Per Share | -90.61 | 16.90 | -54.89 | -39.49 |
| Operating Margin | -1149.52% | -3500.34% | - | - |
| Profit Margin | -980.93% | -2957.63% | - | - |
| Free Cash Flow Margin | -1134.54% | 800.27% | - | - |
| EBITDA | -72.36 | -50.48 | -33.67 | -19.32 |
| D&A For EBITDA | 2.33 | 1.58 | 1.12 | 0.45 |
| EBIT | -74.68 | -52.05 | -34.79 | -19.76 |
Source: S&P Capital IQ. Standard template.
Financial Sources.